Treatment of inflammation, demyelination and neuronal/axonal loss
Details for Australian Patent Application No. 2007308158 (hide)
International Classifications
Event Publications
4 June 2009 PCT application entered the National Phase
PCT publication WO2008/045488 Priority application(s): WO2008/045488
18 June 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 06 May 2009
21 January 2010 Amendment Made
The nature of the amendment is: Amend the applicant name from GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH to Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007308168-Kidney-derived cells and methods of use in tissue repair and regeneration
2007308154-N-aryl pyrazole compounds for use against diabetes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser